Wolverine Trading, LLC Genprex, Inc. Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.59 - $3.36 $5,762 - $7,476	-2,225 Reduced 8.73%	23,252 $62,000
Q2 2021 Aug 06, 2021	BUY	$3.11 - $4.87 $15,260 - $23,897	4,907 Added 23.86%	25,477 $88,000
Q1 2021 May 14, 2021	SELL	$3.66 - $7.67 $20,488 - $42,936	-5,598 Reduced 21.39%	20,570 $84,000
Q4 2020 Feb 12, 2021	BUY	$3.03 - $5.51 $79,289 - $144,185	26,168 New	26,168 $116,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $64.3M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.